activity
20232026
most citedStatistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology

1 citations · 2 across the 3 of their papers we have counts for

collaborators
Showing 2025Show all

1 paper · 1 filter

stat.ME2025

TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials

Hao Sun, Jieqi Tu, Revathi Ananthakrishnan +1

Oncology dose-finding trials are shifting from identifying the maximum tolerated dose (MTD) to determining the optimal biological dose (OBD), driven by the need for efficient metho…